#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Diffuse large B-cell lymphoma Gastric cancer Follicular lymphoma stage I Breast cancer Stress cardiomyopathy Focal segmental glomerulosclerosis Glycogen storage disease type I Astrocytoma malignant Infantile spasms Facioscapulohumeral muscular dystrophy Tuberous sclerosis complex Malformation venous Hormone-dependent prostate cancer Type IIa hyperlipidaemia Eosinophilic oesophagitis More trials…

    Learn about Rare Diseases

    Richter’s syndrome – Trials in Disease Immunodeficiency congenital – Diagnostics Haemophilia A without inhibitors – Diagnostics Chondrosarcoma metastatic – Life with Disease Atypical teratoid/rhabdoid tumour of CNS – Trials in Disease Usher’s syndrome Urea cycle disorder – Treatment Propionic acidaemia – Trials in Disease Fragile X syndrome – Basic Information Indolent systemic mastocytosis – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Clavulanic Acid 4-Hydroxy-N-Desmethyltamoxifen Sym024 Dexketoprofen Trometamol Fostemsavir Zinc Acexamate [18F]Fluoro-Peg-Folate Iopromide Gsk3915393 Reboxetine Mitazalimab Gskvx000000008885 Ly3537982 Messenger Rna Encoding Cas9 Bgb-15025 Citrate BGB-16673 Pacritinib Xtmab-16 Cefixime 2,4 DICHLOROBENZYL ALCOHOL More therapies…

    Learn about Your Condition

    Shock Dementia with Lewy bodies Arthralgia Intermittent claudication Drug use disorder Hypertension Irritable bowel syndrome Leukoencephalopathy Colorectal cancer stage III Yellow fever Onychomycosis Thyroidectomy Alcohol abuse Foetal growth restriction Peripheral spondyloarthritis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Musculoskeletal Diseases

  • Diagnostic Accuracy of 68Ga‑FAPI‑46 PET/CT in Patients with Suspected Giant Cell Arteritis and Polymyalgia Rheumatica

    Not yet recruiting

    2 1 1
    Investigated Drugs:
    • (S)-2,2′,2”-(10-(2-(4-(3-((4-(2-(2-Cyano-4,4-Difluoropyrrolidin-1-Yl)-2-Oxoethylcarbamoyl)-Quinolin-6-Yl)(Methyl)Amino)-Propyl)Piperazin-1-Yl)-2-Oxoethyl)-68Ga-[1,4,7,10]-Tetraazacyclododecane-1,4,7-Triyl)Triacetate
    The Netherlands

  • A study to compare how the body absorbs celecoxib oral suspension and celecoxib capsules in healthy adults for the treatment of acute pain.

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Dysmenorrhoea
    • Pain
    Investigated Drugs:
    • Heparin Sodium
    • Celecoxib
    Czechia

  • Evaluation of the Efficacy, Safety, and Tolerability of Subcutaneous REGN7999 in Adults with Iron Overload Due to Non-Transfusion Dependent Beta-Thalassemia

    Not recruiting

    2 1
    Investigated Drugs:
    • REGN7999
    Greece Italy

  • A study comparing how ritlecitinib capsules work when sprinkled on food versus swallowed whole and with or without food in healthy adults

    Not recruiting

    1 1 1
    Investigated Diseases:
    • Vitiligo
    • Alopecia areata
    • Rheumatoid arthritis
    Belgium

  • A study testing brepocitinib compared to placebo for adults with dermatomyositis to see if it works and is safe

    Not recruiting

    3 1
    Investigated Diseases:
    • Dermatomyositis
    Investigated Drugs:
    • Brepocitinib Tosilate
    Belgium Bulgaria Czechia Germany Hungary Italy +6

  • Study of intra-articular liraglutide (4P004) for patients with knee synovitis and osteoarthritis

    Not recruiting

    2 1
    Investigated Drugs:
    • Liraglutide
    Denmark France Poland Spain
Previous Page
1 … 39 40 41 42 43 … 67
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!